MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: GTCbio - Biopharmaceutical Conference
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Charles Wang of Loma Linda University to Speak at Single Cell Mtg on May 22-23 in Cambridge, Massachusetts - Charles Wang, Director for the Center for Genomics, and Professor of Microbiology and Molecular Genetics at Loma Linda University, to give a presentation at the Inaugural Single Cell Analysis Conference, May 22 & 23, 2014 in Cambridge, MA - GTCbio.com
Charles Wang of Loma Linda University to Speak at Single Cell Mtg on May 22-23 in Cambridge, Massachusetts

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2014/02/10 - Charles Wang, Director for the Center for Genomics, and Professor of Microbiology and Molecular Genetics at Loma Linda University, to give a presentation at the Inaugural Single Cell Analysis Conference, May 22 & 23, 2014 in Cambridge, MA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Charles Wang, Director for the Center for Genomics, and Professor of Microbiology and Molecular Genetics at Loma Linda University to give a presentation titled “Single-Cell Transcriptome Analysis of Mouse Cardiomyocytes Derived Progenitor Cells,” at the Inaugural Single Cell Analysis in Cambridge, MA on May 22-23, 2014 by GTC.

Dr. Wang, MD, PhD, MPH, is Director of the Center for Genomics and a Professor in the Division of Microbiology & Molecular Genetics, School of Medicine, Loma Linda University (LLU).

He held the positions as Director of the Functional Genomics Core at City of Hope National Medical Center, Associate Professor of Medicine at the David Geffen School of Medicine at UCLA and Director of the Clinical Transcriptional Genomics Core at Cedars-Sinai Medical Center before joining LLU. Dr. Wang is a recipient of several awards, including the AACR-Bristol-Myers Squibb Young Investigator Award of the American Association for Cancer Research and the first place graduate award for Research Excellence of Society of Toxicology.

Dr. Wang serves as Editorial Board Members for the Current Stem Cell Research & Therapy, the World Journal of Stem Cells, the Frontiers, and the Single Cell Genomics & Proteomics. Dr. Wang is an expert on genomics and transcriptomics, with many high visibility peer-reviewed papers published in the high profile journals such as Nature Biotechnology, Nature Communications and PNAS. He was one of the project leaders for the FDA-led international working group/consortium on MicroArray Quality Control (MAQC) and Sequencing Quality Control (SEQC) projects.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Charles Wang of Loma Linda University to Speak at Single Cell Mtg on May 22-23 in Cambridge, Massachusetts

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)